Antineoplazice
Lot 1 Cyclophosphamidum 200 mg;
Lot 2 Dacarbazinum 200 mg;
Lot 3 Methotrexatum 10 mg/ml 50 mg;
Methotrexatum 10mg/ml 20 mg;
Methotrexatum 5mg/ml 5 mg;
Lot 4 Pemetrexedum 500 mg;
Lot 5 Fludarabinum 50 mg;
Lot 6 Fluorouracilum 50 mg/ml, 500 mg;
Lot 7 Gemcitabinum conc. pt. sol. perf. 1 000 mg;
Gemcitabinum conc. pt. sol. perf. 200 mg;
Lot 8 Gemcitabinum pulb. pt. sol. perf. 1 000 mg;
Gemcitabinum pulb. pt. sol. perf. 200 mg;
Lot 9 Vinblastinum Sulphas 1 mg/ml, 10 mg/10 ml;
Lot 10 Vincristinum 1 mg;
Lot 11 Vinorelbinum 10 mg/ml, 10 mg;
Lot 12 Vinorelbinum 10 mg/ml, 50 mg;
Lot 13 Etoposidum 100mg/5ml;
Lot 14 Paclitaxelum 6mg/ml, 30 mg;
Paclitaxelum 6 mg/ml, 100 mg;
Paclitaxelum 6 mg/ml, 300 mg;
Lot 15 Docetaxelum 20mg/ml. 140 mg;
Docetaxelum 20 mg/0,5 ml;
Docetaxelum 80 mg/2 ml;
Lot 16 Docetaxelum 20 mg/1ml;
Docetaxelum 80 mg/4ml;
Lot 17 Doxorubicinum 2 mg/ml, 10 mg;
Doxorubicinum conc 2 mg/ml, 50 mg;
Lot 18 Doxorubicinum Liposomal 2 mg/ml, 20 mg;
Doxorubicinum Liposomal 2 mg/ml, 50 mg;
Lot 19 Doxorubicinum pulb 2 mg/ml, 50 mg;
Lot 20 Epirubicinum 2 mg/ml, 100 mg;
Epirubicinum 2 mg/ml, 10 mg;
Epirubicinum 2 mg/ml, 50 mg;
Lot 21 Idarubicinum 5 mg;
Lot 22 Mitoxantronum 2 mg/ml, 20 mg/10ml;
Lot 23 Bleomycinum Sulfas 15 mg;
Lot 24 Cisplatinum 10 mg/20 ml;
Lot 25 Cisplatinum 50 mg/100 ml;
Lot 26 Carboplatinum 10 mg/ml, 150 mg;
Carboplatinum 10 mg/ml, 450 mg;
Lot 27 Oxaliplatinum 5 mg/ml, 100 mg/20 ml;
Oxaliplatinum 5 mg/ml, 50 mg/10ml;
Lot 28 Rituximabum 10 mg/ml, 100 mg;
Rituximabum 10 mg/ml, 500 mg;
Lot 29 Trastuzumabum 150 mg;
Lot 30 Alemtuzumabum 30 mg/ml, 30 mg;
Lot 31 Cetuximabum 5 mg/ml, 100 mg/20 ml;
Lot 32 Bevacizumabum 25 mg/ml, 100 mg;
Bevacizumabum 25 mg/ml, 400 mg;
Lot 33 Temsirolimusum 25 mg/ml, 30 mg;
Lot 34 Topotecamum conc. pt. sol. perf.4 mg/4 ml;
Lot 35 Topotecamum pulb. conc. sol. perf. 4 mg;
Lot 36 Irinotecanum 20mg/ml, 100 mg;
Irinotecanum 20 mg/ml, 300 mg;
Lot 37 Bortezomibum 3,5 mg;
Lot 38 Leuprorelinum 11,25 mg;
Leuprorelinum 3,75 mg;
Lot 39 Goserelinum 10,8 mg;
Goserelinum 3,6 mg;
Lot 40 Triptorelinum 11,25 mg;
Triptorelinum 3,75 mg;
Lot 41 Filgrastimum (G-CSF) 30 MU/0,5ml;
Lot 42 Filgrastimum (G-CSF) 60 MU/ml;
Lot 43 Filgrastimum (G-CSF) 300 mcg/0,5ml;
Lot 44 Pegfilgrastimum 6 mg/0,6 ml;
Lot 45 Interferonum Alfa 2A 3Mui/0,5ml;
Interferonum Alfa 2A 9Mui/0,5ml;
Lot 46 Interferonum Alfa 2B 18 milioane UI;
Interferonum Alfa 2B 30 milioane UI;
Lot 47 Acidum Clodronicum 300 mg/5 ml;
Lot 48 Acidum Clodronicum 60 mg/ml, 300 mg;
Lot 49 Acidum Pamidronicum 15 mg;
Lot 50 Acidum Pamidronicum 30 mg;
Acidum Pamidronicum 60 mg;
Lot 51 Acidum Ibandronicum 6 mg/6 ml;
Lot 52 Acidum Zoledronicum 4 mg/5 ml;
Lot 53 Ifosfamidum 1 000 mg;
Lot 54 Mesnum 400mg/4 ml;
Lot 55 Calcii Folinas 10 mg/ml, 100 mg;
Calcii Folinas 10mg/ml, 30 mg;
Lot 56 Calcii Folinas 3mg/ml, 30 mg;
Lot 57 Fulvestrant 250 mg/5 ml;
Lot 58 Leuprorelinum 22,5 mg.
Termen limită
Termenul de primire a ofertelor a fost de 2013-08-05.
Achiziția publică a fost publicată pe 2013-06-12.
Furnizori
Următorii furnizori sunt menționați în deciziile de atribuire sau în alte documente de achiziții publice:
Cine?
Ce?
Unde?
Istoricul achizițiilor
Data |
Document |
2013-06-12
|
Anunţ de participare
|
2013-06-26
|
Informaţii suplimentare
|
2013-11-21
|
Anunt de atribuire
|